Healthcare provider profile · identity verified

Emily Hedum, DO

Family Practice · HELENA, MT · NPI 1144665795

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	428	66
Levothyroxine Sodium	Levothyroxine Sodium	314	52
Gabapentin	Gabapentin	310	33
Eliquis	Apixaban	265	23
Furosemide	Furosemide	263	33
Lisinopril	Lisinopril	239	35
Trazodone Hcl	Trazodone Hcl	198	33
Duloxetine Hcl	Duloxetine Hcl	193	22
Omeprazole	Omeprazole	186	39
Metformin Hcl	Metformin Hcl	183	21
Sertraline Hcl	Sertraline Hcl	169	15
Amlodipine Besylate	Amlodipine Besylate	164	25
Tamsulosin Hcl	Tamsulosin Hcl	161	27
Metoprolol Succinate	Metoprolol Succinate	160	24
Mirtazapine	Mirtazapine	160	18
Losartan Potassium	Losartan Potassium	149	22
Potassium Chloride	Potassium Chloride	133	26
Fluoxetine Hcl	Fluoxetine Hcl	132	14
Tramadol Hcl	Tramadol Hcl	121	20
Clopidogrel	Clopidogrel Bisulfate	116	11
Baclofen	Baclofen	112	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	100	suppressed
Olanzapine	Olanzapine	100	13
Oxycodone Hcl	Oxycodone Hcl	97	26
Allopurinol	Allopurinol	94	suppressed
Metformin Hcl Er	Metformin Hcl	89	14
Risperidone	Risperidone	83	suppressed
Simvastatin	Simvastatin	83	15
Lamotrigine	Lamotrigine	80	suppressed
Carvedilol	Carvedilol	79	15
Ropinirole Hcl	Ropinirole Hcl	77	suppressed
Buspirone Hcl	Buspirone Hcl	74	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	73	suppressed
Aripiprazole	Aripiprazole	72	suppressed
Memantine Hcl	Memantine Hcl	69	suppressed
Citalopram Hbr	Citalopram Hydrobromide	66	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	63	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	16
Levetiracetam	Levetiracetam	62	suppressed
Meloxicam	Meloxicam	62	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	58	39
Lorazepam	Lorazepam	54	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	54	suppressed
Pregabalin	Pregabalin	51	suppressed
Atenolol	Atenolol	49	suppressed
Prednisone	Prednisone	49	11
Amiodarone Hcl	Amiodarone Hcl	48	suppressed
Divalproex Sodium	Divalproex Sodium	47	suppressed
Donepezil Hcl	Donepezil Hcl	47	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	46	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	46	suppressed
Prazosin Hcl	Prazosin Hcl	46	suppressed
Diclofenac Sodium	Diclofenac Sodium	43	17
Glipizide	Glipizide	43	suppressed
Warfarin Sodium	Warfarin Sodium	42	suppressed
Xarelto	Rivaroxaban	42	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	41	14
Spironolactone	Spironolactone	41	suppressed
Haloperidol	Haloperidol	40	suppressed
Pravastatin Sodium	Pravastatin Sodium	40	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	39	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	38	suppressed
Topiramate	Topiramate	38	suppressed
Finasteride	Finasteride	37	suppressed
Ondansetron Hcl	Ondansetron Hcl	37	20
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Famotidine	Famotidine	36	11
Torsemide	Torsemide	35	suppressed
Alendronate Sodium	Alendronate Sodium	34	12
Bupropion Xl	Bupropion Hcl	34	suppressed
Celecoxib	Celecoxib	32	suppressed
Cephalexin	Cephalexin	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	31	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	30	17
Leflunomide	Leflunomide	30	suppressed
Montelukast Sodium	Montelukast Sodium	30	suppressed
Budesonide	Budesonide	29	suppressed
Clonidine Hcl	Clonidine Hcl	29	suppressed
Loperamide	Loperamide Hcl	29	suppressed
Propranolol Hcl	Propranolol Hcl	29	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	29	suppressed
Glimepiride	Glimepiride	27	suppressed
Primidone	Primidone	27	suppressed
Enalapril Maleate	Enalapril Maleate	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	23	suppressed
Imiquimod	Imiquimod	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Risperidone Odt	Risperidone	22	suppressed
Nystatin	Nystatin	21	16
Phenobarbital	Phenobarbital	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Trintellix	Vortioxetine Hydrobromide	20	suppressed
Fentanyl	Fentanyl	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Movantik	Naloxegol Oxalate	19	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	18	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	18	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	18	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Lactulose	Lactulose	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Azathioprine	Azathioprine	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Insulin Aspart Flexpen	Insulin Aspart	16	suppressed
Letrozole	Letrozole	16	suppressed
Mesalamine Er	Mesalamine	16	suppressed
Myrbetriq	Mirabegron	15	suppressed
Colchicine	Colchicine	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Low-Ogestrel	Norgestrel-Ethinyl Estradiol	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Roflumilast	Roflumilast	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Valproic Acid	Valproic Acid	12	suppressed
Dexamethasone	Dexamethasone	11	suppressed
Phenytoin	Phenytoin	11	suppressed
Prednisolone Acetate	Prednisolone Acetate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error